obesity

Targeting GLP-1 and GIP in Obesity and Type 2 Diabetes Research

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.